Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
mepolizumab (344) 344
life sciences & biomedicine (227) 227
science & technology (227) 227
asthma (177) 177
humans (119) 119
omalizumab (107) 107
immunology (93) 93
allergy (87) 87
benralizumab (77) 77
reslizumab (73) 73
respiratory system (69) 69
asthma - drug therapy (64) 64
severe asthma (57) 57
monoclonal antibodies (54) 54
il-5 (52) 52
patients (51) 51
antibodies, monoclonal, humanized - therapeutic use (50) 50
dupilumab (48) 48
eosinophils (48) 48
pharmacology & pharmacy (43) 43
leukocytes (42) 42
female (40) 40
anti-asthmatic agents - therapeutic use (39) 39
male (39) 39
adult (35) 35
antibodies, monoclonal - therapeutic use (35) 35
interleukin-5 - antagonists & inhibitors (34) 34
cytokines (33) 33
eosinophils - immunology (32) 32
clinical trials (31) 31
inflammation (31) 31
interleukin-5 - immunology (31) 31
middle aged (31) 31
case report (29) 29
corticosteroids (29) 29
interleukin 5 (29) 29
eosinophilia (28) 28
interleukin-5 (28) 28
treatment outcome (28) 28
abridged index medicus (27) 27
severe eosinophilic asthma (27) 27
drug therapy (26) 26
quality of life (26) 26
biologics (25) 25
eosinophil (24) 24
severity of illness index (24) 24
eosinophilic asthma (23) 23
review (23) 23
allergies (22) 22
asthma - immunology (22) 22
care and treatment (22) 22
anti-il-5 (21) 21
corticoids (21) 21
biomarkers (20) 20
drug dosages (20) 20
general & internal medicine (20) 20
internal medicine (20) 20
animals (19) 19
asthma - physiopathology (19) 19
eosinophilia - drug therapy (19) 19
eosinophilic granulomatosis with polyangiitis (19) 19
hypereosinophilic syndrome (19) 19
immunoglobulin e (19) 19
respiratory tract diseases (19) 19
adolescent (18) 18
diseases of the respiratory system (18) 18
immunologic diseases. allergy (18) 18
interleukins (18) 18
antibodies, monoclonal, humanized (17) 17
biological and medical sciences (17) 17
eosinophilic esophagitis (17) 17
medical sciences (17) 17
medicine & public health (17) 17
studies (17) 17
analysis (16) 16
eosinophils - drug effects (16) 16
medicine, general & internal (16) 16
safety (16) 16
blood (15) 15
child (15) 15
immunotherapy (15) 15
medical research (15) 15
pediatrics (15) 15
anti-asthmatic agents - administration & dosage (14) 14
biological products (14) 14
chronic obstructive pulmonary disease (14) 14
eosinophils - metabolism (14) 14
interleukin-5 - metabolism (14) 14
medicine (14) 14
research (14) 14
allergy and immunology (13) 13
antibodies (13) 13
biological therapy (13) 13
children (13) 13
exacerbations (13) 13
health aspects (13) 13
immunoglobulins (13) 13
lebrikizumab (13) 13
vasculitis (13) 13
young adult (13) 13
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (329) 329
French (10) 10
German (9) 9
Russian (6) 6
Chinese (2) 2
Spanish (2) 2
Italian (1) 1
Japanese (1) 1
Korean (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Role of Cytokines in EGPA and the Possibility of Treatment with an Anti-IL-5 Antibody
by Isozaki, Takeo and Homma, Tetsuya and Sagara, Hironori and Kasama, Tsuyoshi
Journal of clinical medicine, ISSN 2077-0383, 11/2020, Volume 9, Issue 12, p. 3890
IL-5 | cytokines | EGPA | mepolizumab
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab
by Landi, Claudia and Cameli, Paolo and Vantaggiato, Lorenza and Bergantini, Laura and d'Alessandro, Miriana and Perruzza, Marco and Carleo, Alfonso and Shaba, Enxhi and Di Giuseppe, Fabrizio and Angelucci, Stefania and Bargagli, Elena and Bini, Luca
Biochimica et biophysica acta. Proteins and proteomics, ISSN 1570-9639, 02/2021, Volume 1869, Issue 2, pp. 140563 - 140563
Benralizumab | Serum | Redox proteomics | Severe eosinophilic asthma | Mepolizumab | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Biological Therapies of Severe Asthma and Their Possible Effects on Airway Remodeling
by Kardas, Grzegorz and Kuna, Piotr and Panek, Michal
Frontiers in immunology, ISSN 1664-3224, 06/2020, Volume 11, pp. 1134 - 1134
Life Sciences & Biomedicine | Immunology | Science & Technology | Omalizumab | Care and treatment | Asthma | Index Medicus | asthma | omalizumab | airway remodeling in asthma | mepolizumab/reslizumab | biological therapy | airway remodeling
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials
by Lan, Shao-Huan and Lai, Chih-Cheng and Chang, Shen-Peng and Hsu, Chun-Chun and Chen, Cheng-Hsin and Wang, Ya-Hui and Huang, Yueh Lan and Wang, Cheng-Yi and Lin, You-Shuei
Journal of microbiology, immunology and infection, ISSN 1684-1182, 12/2020
Benralizumab | Anti-IL-5 | Mepolizumab | Eosinophil | COPD | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text One year of mepolizumab. Efficacy and safety in real-life in Italy
by Bagnasco, Diego and Caminati, Marco and Menzella, Francesco and Milanese, Manlio and Rolla, Giovanni and Lombardi, Carlo and Bucca, Caterina and Heffler, Enrico and Paoletti, Giovanni and Testino, Elisa and Manfredi, Andrea and Caruso, Cristiano and Guida, Giuseppe and Senna, Gianenrico and Bonavia, Marco and Riccio, Anna Maria and Canonica, Giorgio Walter and Passalacqua, Giovanni
Pulmonary pharmacology & therapeutics, ISSN 1094-5539, 10/2019, Volume 58, pp. 101836 - 101836
Real life | Biologics | IL-5 | Exacerbations | Severe asthma | Safety | Mepolizumab | OCS | Asthma | Eosinophils | Quality of life | Pharmacology & Pharmacy | Respiratory System | Life Sciences & Biomedicine | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)
by Bateman, Eric D and Khan, Asif H and Xu, Yingxin and Guyot, Patricia and Chao, Jingdong and Kamat, Siddhesh and Rowe, Paul and Burnett, Heather and Msihid, Jerome and Weinreich, David M and Pavord, Ian D
Respiratory medicine, ISSN 0954-6111, 08/2020, pp. 106106 - 106106
Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text No Effect of Anti-Interleukin-5 Therapy (Mepolizumab) on the Atopy Patch Test in Atopic Dermatitis Patients
by Oldhoff, J.M and Darsow, U and Werfel, T and Bihari, I.C and Katzer, K and Laifaoui, J and Plötz, S and Kapp, A and Knol, E.F and Bruijnzeel-Koomen, C.A.F.M and Ring, J and de Bruin-Weller, M.S
International archives of allergy and immunology, ISSN 1018-2438, 10/2006, Volume 141, Issue 3, pp. 290 - 294
Original Paper | Anti-interleukin-5 antibody | Atopic dermatitis | Mepolizumab | Atopy patch test | Eosinophils | Skin biopsies | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Fundamental immunology | Immunopathology | Skin allergic diseases. Stinging insect allergies | Biological and medical sciences | Allergic diseases | Medical sciences | Eosinophils - drug effects | Interleukin-5 - metabolism | Cell Count | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Dermatitis, Atopic - physiopathology | Eosinophils - immunology | Antibodies, Monoclonal, Humanized | Dermatitis, Atopic - drug therapy | Interleukin-5 - antagonists & inhibitors | Treatment Failure | Dermatitis, Atopic - immunology | Adult | Female | Patch Tests | Monoclonal antibodies | Cytokines | Drug therapy | Dermatitis | Diagnostic tests | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Response to the correspondence: “Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma”
by Bateman, Eric D and Khan, Asif H and Xu, Yingxin and Guyot, Patricia and Chao, Jingdong and Kamat, Siddhesh and Rowe, Paul and Burnett, Heather and Msihid, Jerome and Weinreich, David and Pavord, Ian D
Respiratory medicine, ISSN 0954-6111, 07/2020, p. 106088
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Real‐word experience with mepolizumab: Does it deliver what it has promised?
by Schleich, Florence and Graff, Sophie and Nekoee, Haleh and Moermans, Catherine and Henket, Monique and Sanchez, Carole and Paulus, Virginie and Guissard, Françoise and Donneau, Anne‐Françoise and Louis, Renaud
Clinical and experimental allergy, ISSN 0954-7894, 06/2020, Volume 50, Issue 6, pp. 687 - 695
severe asthma | eosinophils | sputum | lung function | exacerbations | mepolizumab | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma
by Bourdin, Arnaud and Molinari, Nicolas
Respiratory medicine, ISSN 0954-6111, 05/2020, p. 105999
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
by Bachert, Claus and Sousa, Ana R and Lund, Valerie J and Scadding, Glenis K and Gevaert, Philippe and Nasser, Shuaib and Durham, Stephen R and Cornet, Marjolein E and Kariyawasam, Harsha H and Gilbert, Jane and Austin, Daren and Maxwell, Aoife C and Marshall, Richard P and Fokkens, Wytske J
Journal of allergy and clinical immunology, ISSN 0091-6749, 10/2017, Volume 140, Issue 4, pp. 1024 - 1031.e14
Nasal polyposis | chronic rhinosinusitis | IL-5 | eosinophil | mepolizumab | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Severity of Illness Index | Immunotherapy - methods | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Middle Aged | Male | Nasal Polyps - surgery | Treatment Outcome | Nasal Polyps - drug therapy | Eosinophils - immunology | Disease Progression | Interleukin-5 - immunology | Young Adult | Adolescent | Adult | Female | Aged | Endoscopy | Surgery | Clinical trials | Corticoids | Intravenous administration | Corticosteroids | Leukocytes (eosinophilic) | Mucus | Inflammation | Patients | Polyposis | Pharynx | Visual perception | Blockage | Asthma | Smell | Endoscopes | Nose | Olfaction | Safety | Steroids | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine
by Pavord, Ian D and Menzies-Gow, Andrew and Buhl, Roland and Chanez, Pascal and Dransfield, Mark and Lugogo, Njira and Keene, Oliver N and Bradford, Eric S and Yancey, Steve W
The journal of allergy and clinical immunology in practice (Cambridge, MA), ISSN 2213-2198, 2020
Severe eosinophilic asthma | Anti-IL-5 | Mepolizumab | Biologic therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Mepolizumab failed to affect bullous pemphigoid: A randomized, placebo‐controlled, double‐blind phase 2 pilot study
by Simon, Dagmar and Yousefi, Shida and Cazzaniga, Simone and Bürgler, Christina and Radonjic, Susanne and Houriet, Carine and Heidemeyer, Kristine and Klötgen, Hans‐Wilhelm and Kozlowski, Evelyne and Borradori, Luca and Simon, Hans‐Uwe
Allergy (Copenhagen), ISSN 0105-4538, 03/2020, Volume 75, Issue 3, pp. 669 - 672
bullous pemphigoid | eosinophil | interleukin‐5 | mepolizumab | interleukin-5 | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Pemphigoid | Bullous pemphigoid | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities
by Crimi, Claudia and Campisi, Raffaele and Cacopardo, Giulia and Intravaia, Rossella and Nolasco, Santi and Porto, Morena and Pelaia, Corrado and Crimi, Nunzio
The World Allergy Organization journal, ISSN 1939-4551, 09/2020, Volume 13, Issue 9, pp. 100462 - 100462
Mepolizumab | Multiple comorbidities | Severe eosinophilic asthma | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text BT or MAb: That is the question
by Wechsler, Michael E
Respirology (Carlton, Vic.), ISSN 1323-7799, 12/2020, Volume 25, Issue 12, pp. 1222 - 1222
severe asthma | monoclonal antibody | bronchial thermoplasty | mepolizumab | Monoclonal antibodies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life data
by Renner, Andreas and Marth, Katharina and Patocka, Karin and Idzko, Marco and Pohl, Wolfgang
Pulmonary pharmacology & therapeutics, ISSN 1094-5539, 10/2020, Volume 64, pp. 101946 - 101946
Asthma treatment | Real-world study | FEV1 | Biomarker profile | Anti-IL-5 | ACT score | Mepolizumab | Asthma | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights